Pembrolizumab for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer and Preexisting Interstitial Lung Disease

OBJECTIVE: Pembrolizumab has benefited patients with advanced non-small-cell lung cancer (NSCLC) with a programmed death-ligand (PD-L)1 high expression, but little information is available regarding its safety for patients with interstitial lung disease (ILD). The aim of this study was to assess the...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Intern Med
Main Authors: Fujita, Tetsuo, Kuroki, Tsuguko, Hayama, Nami, Shiraishi, Yuka, Amano, Hiroyuki, Nakamura, Makoto, Hirano, Satoshi, Tabeta, Hiroshi, Nakamura, Sukeyuki
Format: Artigo
Sprog:Inglês
Udgivet: The Japanese Society of Internal Medicine 2020
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7492129/
https://ncbi.nlm.nih.gov/pubmed/32389949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.4552-20
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker